Thermo Fisher Considers Sale of $1 Billion Pathology Unit

(Bloomberg) -- Thermo Fisher Scientific Inc., the maker of diagnostic and testing equipment, is considering a sale of its anatomical pathology unit in a deal that could fetch about $1 billion, peop...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.